Statin-Mediated Reduction in Risk of Stroke Is Independent of the Extent of Low-Density Lipoprotein Cholesterol Lowering

被引：0
|
作者：
Alsheikh-Ali, Alawi A. [1 ]
Jafri, Haseeb [1 ]
Kimmelstiel, Carey [1 ]
Karas, Richard H. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A203 / A203
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
    Voora, Deepak
    Shah, Svati H.
    Reed, Carol R.
    Zhai, Jun
    Crosslin, David R.
    Messer, Chad
    Salisbury, Benjamin A.
    Ginsburg, Geoffrey S.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2008, 1 (02) : 100 - 106
  • [2] Statin-Mediated Low-Density Lipoprotein Lowering in Chronic Congestive Heart Failure
    Kosmas, Constantine E.
    Alkhawam, Hassan
    El-Hunjul, Mohammed
    Wagman, Gabriel
    Kahn, Mark R.
    Grady, Kathleen M.
    Vittorio, Timothy J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (01): : 14 - 22
  • [3] A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering
    Leusink, Maarten
    Maitland-van der Zee, Anke H.
    Ding, Bo
    Drenos, Fotios
    van Iperen, Erik P. A.
    Warren, Helen R.
    Caulfield, Mark J.
    Cupples, L. Adrienne
    Cushman, Mary
    Hingorani, Aroon D.
    Hoogeveen, Ron C.
    Hovingh, G. Kees
    Kumari, Meena
    Lange, Leslie A.
    Munroe, Patricia B.
    Nyberg, Fredrik
    Schreiner, Pamela J.
    Sivapalaratnam, Suthesh
    de Bakker, Paul I. W.
    de Boer, Anthonius
    Keating, Brendan J.
    Asselbergs, Folkert W.
    Onland-Moret, N. Charlotte
    PHARMACOGENOMICS, 2016, 17 (06) : 583 - 591
  • [4] Addition of ezetimibe to ongoing statin therapy: incremental reduction in low-density lipoprotein cholesterol is independent of statin type
    Mata, P
    Gumbiner, B
    Musliner, T
    Quinto, K
    Cho, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [5] The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?
    Khera, Amit V.
    Natarajan, Pradeep
    Kathiresan, Sekar
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1062 - 1064
  • [6] Low-density lipoprotein cholesterol and the risk of dementia with stroke
    Moroney, JT
    Tang, MX
    Berglund, L
    Small, S
    Merchant, C
    Bell, K
    Stern, Y
    Mayeux, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03): : 254 - 260
  • [7] Alirocumab for low-density lipoprotein cholesterol lowering
    Roth, Eli M.
    FUTURE CARDIOLOGY, 2019, 15 (01) : 17 - 29
  • [8] Evidence for statin-mediated functions independent of lipid lowering
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (9): : 465 - 465
  • [9] Effects of Statin Intensity and Low-density Lipoprotein Cholesterol Lowering in Korean Patients With Chronic Ischemic Heart Disease and Very Low Low-density Lipoprotein Cholesterol
    Lee, Soo Youn
    Youn, Jong-Chan
    Park, Sungha
    Kang, Seok-Min
    Choi, Donghoon
    Oh, Seung Jin
    Kim, Eung Ju
    Lee, Sang-Hak
    CIRCULATION, 2015, 132
  • [10] Optimal low-density lipoprotein cholesterol lowering - Morning versus evening statin administration
    Plakogiannis, Roda
    Cohen, Henry
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 106 - 110
12345